Home › Funds › Sofinnova Investments, Inc. › JAZZ

Sofinnova Investments, Inc. position in JAZZ

JAZZ PHARMACEUTICALS PLC · Health Care

Sofinnova Investments, Inc. reported holding 422,375 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$97.8M, representing 4.42% of its reported portfolio and ranking #4 among its reported holdings. Sofinnova Investments, Inc. has disclosed JAZZ holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)422.38K sh
Reported value held$97.79M
Portfolio Weight4.42%
First reportedQ3 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s JAZZ position evolved

Sofinnova Investments, Inc. first disclosed a stake in JAZZ in Q3 2024 at 188,562 shares (US$21.0M). The position peaked in Q4 2025 at 959,860 shares, worth US$163.2M. Across 9 filings, Sofinnova Investments, Inc. increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 422,375 shares valued at US$97.8M — an increase of 57,034 shares quarter over quarter.. Notable position changes include a 167% increase in Q4 2024 (shares were roughly flat over the following quarter), a 63% increase in Q4 2025 (shares rose 11% over the following quarter), a 39% trim in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 188.56K $21.01M New
Q4 2024 504.19K $62.09M Add
Q1 2025 510.05K $63.32M Add
Q2 2025 694.10K $73.66M Add
Q3 2025 588.83K $77.61M Reduce
Q4 2025 959.86K $163.18M Add
Q1 2026 598.33K $113.11M Reduce
Q2 2026 365.34K $88.04M Reduce
Q3 2026 422.38K $97.79M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 40 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), Boston Trust Walden Corp (US$98.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has Sofinnova Investments, Inc. held JAZZ?

Sofinnova Investments, Inc. has disclosed JAZZ holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Sofinnova Investments, Inc.'s current position in JAZZ?

As of Q3 2026, Sofinnova Investments, Inc. holds 422.38K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $97.79M, representing 4.42% of its reported portfolio and ranking #4.

Has Sofinnova Investments, Inc. been buying or selling JAZZ?

In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. increased its position in JAZZ. The position peaked in Q4 2025 at 959.86K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, Boston Trust Walden Corp, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.